These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
583 related items for PubMed ID: 19410461
1. Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII. Güzel O, Maresca A, Scozzafava A, Salman A, Balaban AT, Supuran CT. Bioorg Med Chem Lett; 2009 Jun 01; 19(11):2931-4. PubMed ID: 19410461 [Abstract] [Full Text] [Related]
4. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. Puccetti L, Fasolis G, Vullo D, Chohan ZH, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3096-101. PubMed ID: 15908204 [Abstract] [Full Text] [Related]
6. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides. Güzel O, Innocenti A, Scozzafava A, Salman A, Parkkila S, Hilvo M, Supuran CT. Bioorg Med Chem; 2008 Oct 15; 16(20):9113-20. PubMed ID: 18819811 [Abstract] [Full Text] [Related]
7. Carbonic anhydrase inhibitors: benzenesulfonamides incorporating cyanoacrylamide moieties are low nanomolar/subnanomolar inhibitors of the tumor-associated isoforms IX and XII. Alafeefy AM, Isik S, Abdel-Aziz HA, Ashour AE, Vullo D, Al-Jaber NA, Supuran CT. Bioorg Med Chem; 2013 Mar 15; 21(6):1396-403. PubMed ID: 23290254 [Abstract] [Full Text] [Related]
8. New Pyridinium Salt Derivatives of 2-(Hydrazinocarbonyl)-3-phenyl-1H-indole-5- sulfonamide as Selective Inhibitors of Tumour-Related Human Carbonic Anhydrase Isoforms IX and XII. Güzel-Akdemir Ö, Demir-Yazıcı K, Vullo D, Supuran CT, Akdemir A. Anticancer Agents Med Chem; 2022 Mar 15; 22(14):2637-2646. PubMed ID: 35135455 [Abstract] [Full Text] [Related]
13. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties. Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT. Bioorg Med Chem Lett; 2004 Nov 01; 14(21):5427-33. PubMed ID: 15454239 [Abstract] [Full Text] [Related]
14. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J, Szafrański K, Vullo D, Supuran CT. Eur J Med Chem; 2013 Nov 01; 69():701-10. PubMed ID: 24095761 [Abstract] [Full Text] [Related]
18. Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII. Rami M, Maresca A, Smaine FZ, Montero JL, Scozzafava A, Winum JY, Supuran CT. Bioorg Med Chem Lett; 2011 May 15; 21(10):2975-9. PubMed ID: 21470859 [Abstract] [Full Text] [Related]
19. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII. Rodríguez OM, Maresca A, Témpera CA, Bravo RD, Colinas PA, Supuran CT. Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4447-50. PubMed ID: 21723123 [Abstract] [Full Text] [Related]